{
  "id": 3560448,
  "title": "Axogen stock hits 52-week high at 51.13 USD",
  "url": "https://urgent.news/2026/08/26/axogen-stock-hits-52-week-high-at-51-13-usd",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-26T18:02:17.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/axogen-stock-hits-52week-high-at-5113-usd-93CH-4877719"
  },
  "original_language": "en",
  "account": null,
  "summary": "Axogen Inc's stock has reached a 52-week high of 51.13 USD, marking a significant increase of 214.19% over the past year. The medical device company, with a market capitalization of 2.73 billion USD, reported a 23% revenue growth in Q2 2026, reaching $69.7 million, which surpassed Wall Street's estimate of $67.1 million. Despite posting a net loss of $1.5 million, Axogen's strong financial performance has caught the attention of several analysts, with H.C. Wainwright raising its price target to $53, maintaining a Buy rating, and Citizens increasing its target to $55. Truist Securities also initiated coverage on Axogen with a Buy rating and a price target of $60, acknowledging the company's growth potential in the peripheral nerve repair market.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Apogee Therapeutics stock hits all-time high at 134.89 USD",
        "url": "https://urgent.news/2026/08/26/apogee-therapeutics-stock-hits-all-time-high-at-134-89-usd",
        "published": "2026-08-26T16:35:59.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}